Nathan Connell: New Research on Heavy Menstrual Bleeding in Women With von Willebrand Disease
Nathan Connell, Clinical Chief of Hematology at Brigham and Women’s Faulkner Hospital, shared on LinkedIn:
“New research on heavy menstrual bleeding in women with von Willebrand disease
This open-access article in Haemophilia Journal focuses on heavy menstrual bleeding (HMB) in women with von Willebrand disease.
While VWD is the most common inherited bleeding disorder, its impact on women’s health, particularly HMB, is often underdiagnosed. This research is a crucial reminder of the importance of considering underlying bleeding disorders in women presenting with HMB.
Key takeaways from the article and related research:
- HMB is a highly prevalent symptom in women with VWD, affecting a significant majority of patients.
- The article reinforces that HMB in women with VWD can lead to complications such as iron deficiency anemia, which severely impacts a person’s quality of life.
- Diagnosis can be challenging as VWF levels can fluctuate. The article stresses the importance of proper hemostatic testing and a detailed patient history to avoid misdiagnosis.
- Effective management strategies for HMB in women with VWD are discussed, including hormonal therapies, antifibrinolytic drugs, and in some cases, VWF/FVIII concentrate.
This is a vital topic for hematologists, gynecologists, and primary care physicians to collaborate on, ensuring women receive the correct diagnosis and treatment.”
Title: Prevalence and Impact of Heavy Menstrual Bleeding in Women With von Willebrand Disease Across Age Groups: A Retrospective Study
Authors: Anna Olsson, Petra Elfvinge, Eva Zetterberg, Linda Myrin-Westesson
Read the full paper here.
Stay informed with Hemostasis Today.
-
Jan 7, 2026, 08:50Fahad Khaliq on When is Ticagrelor Preferred Over Other Antiplatelets
-
Jan 7, 2026, 06:41Zain Khalpey on AI Driven Risk Prediction for Optimization of Anticoagulation in LVAD
-
Jan 7, 2026, 05:47Michael Makris: The Wakley Prize Essay Published in Today’s Lancet is an Excellent Read
-
Jan 7, 2026, 05:36Pierre F Sabouret Shares A Study on the Risk of Cardiovascular Death in SIDs
-
Jan 7, 2026, 05:15Glaivy Batsuli Reflects on ASH25
-
Jan 7, 2026, 05:04Heghine Khachatryan on VWD: A Landmark in the History of Hematology
-
Jan 6, 2026, 13:39JAMA Neurology: No Added Benefit of Dual Therapy After Ischemic Stroke in Case of AFib
-
Jan 6, 2026, 10:10This is Fantastic: Shirley D’Sa on Transfusion-Free Christmas Milestone for 𝛃-Thalassaemia Patient at UCLH
-
Jan 6, 2026, 09:53Hamideh Yadegari: Coagulation–Inflammation Crosstalk: Mechanisms, Pathways, and Clinical Implications